Eric Hedrick - 25 Feb 2022 Form 4 Insider Report for EQRx, Inc.

Reporting relationship: Chief Physician Executive
Issuer ticker: N/A
Reported as of: 25 Feb 2022
Net transaction value: $0
SEC form: 4
Accepted by SEC: 01 Mar 2022, 16:31:30 UTC
Prior SEC filing: 20 Dec 2021
Next SEC filing: 04 Jan 2023
Source filing: View source filing
Reporting owner signature: /s/ William Collins, Attorney-in-Fact

Key filing fact

Eric Hedrick filed Form 4 for EQRx, Inc. on 01 Mar 2022.

Key facts

This page summarizes Eric Hedrick's Form 4 filing for EQRx, Inc..
1 reported transaction and 1 derivative row are listed below.
Accepted by SEC: 01 Mar 2022, 16:31.

Change

Previous filing in this sequence was filed on 20 Dec 2021.
Current net transaction value: $0.

Research use

This tells you what this filing adds before you inspect full transaction and derivative tables.
You can trace every row back to the original SEC filing document.

Evidence

Filed on Form 4

Ownership activity is grounded in SEC Form 4 disclosures.

View source filing

Reported derivative securities

Options, warrants, convertible securities, or similar derivative positions disclosed in the filing.

EQRX transaction Derivative

Stock Option (Right to Buy)

Award

Transaction value: $0
Shares: +505,051
Change %
Price: $0.000000
Shares after: 505,051
Date: 25 Feb 2022
Ownership: Direct
Underlying class: Common Stock
Underlying amount: 505,051
Exercise price: $3.03
Footnotes: F1

^* marks a reported price that did not pass the local price check.

Additional SEC filing notes

Filing notes and footnotes

Explanation of responses 1 footnote

Footnote F1

The shares underlying this option vest and become exercisable in 48 equal monthly installments commencing February 1, 2022, subject to the Reporting Person's continuous service as of each vesting date.